Cytokeratin 14 expression in epithelial neoplasms: A survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours

Histopathology

Volumn 39, Issue 1, 2001, Pages 9-16

  Chu, P G ^a   Lyda, M H ^a   Weiss, L M ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Cytokeratin 14; Epithelial neoplasms; Immunohistochemistry; Squamous cell carcinoma

Indexed keywords

CYTOKERATIN; CYTOKERATIN 14; MONOCLONAL ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM CARCINOMA; EPITHELIUM TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT MESOTHELIOMA; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; SQUAMOUS CELL CARCINOMA; THYMOMA; THYROID CANCER; TISSUE DISTRIBUTION; TRANSITIONAL CELL CARCINOMA; TUMOR CELL LINE; TUMOR DIFFERENTIATION; WARTHIN TUMOR;

CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-14; KERATINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; PREDICTIVE VALUE OF TESTS;

EID: 0034858199     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2001.01105.x     Document Type: Article

References (24)

1. Adenomyoepithelioma of the breast. A spectrum of biologic behavior
2. Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast
3. Double immunolabeling with cytokeratin and smooth-muscle actin in confirming early invasive carcinoma of breast
4. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: Strategies, applications and limitations
5. Basal cell specific and hyperproliferation-related keratins in human breast cancer
6. The catalog of human cytokeratins: Pattern of expression in normal epithelia, tumor and culture cells
7. Antibody markers of basal cells in complex epithelia
8. Regulation of terminal differentiation of cultured human keratinocytes by vimentin A
9. Expression of keratin mRNAs and proteins in normal salivary epithelia and pleomorphic adenomas
10. Immunofluorescence staining of keratin fibers in cultured cells
11. Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas
12. The limited difference between keratin patterns of squamous cell carcinomas and adenocarcinomas is explicable by both cell lineage and state of differentiation of tumour cells
13. Cytokeratin 10/13, 14, 7, 8, and 18 in invasive squamous cell carcinoma and adenocarcinoma of the uterine cervix
14. Immunohistochemistry of cytokeratin proteins in squamous and transitional cell lesions of the urinary tract
15. A clinicopathologic study of squamous cell carcinoma of the bladder
16. Squamous cell carcinoma of the bladder
17. Involucrin and tumor progression in the uterine cervix
18. Keratin and involucrin immuno-histochemistry of nasopharyngeal carcinoma
19. Changes of cytokeratin and involucrin expression in squamous cell carcinomas of the skin during progression to malignancy
20. Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin
21. Involucrin expression in urinary bladder carcinoma
22. Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue
23. Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins
24. Antibodies to cytokeratin 14 specially identify oncocytes (Hurthle cells) in thyroid lesions and tumors